Early Phase 1 Stomach Cancer Trial, Recruiting NCT07034742 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Stomach Cancer
Back to Stomach Cancer

Early Phase 1 Stomach Cancer Trial, Recruiting

NCT07034742
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific type of stomach or gastroesophageal junction (the area where the food pipe meets the stomach) cancer, confirmed by a tissue sample — specifically adenocarcinoma, mucinous adenocarcinoma, or signet ring cell carcinoma.
  • Your cancer is at a stage where it has grown into surrounding tissues but has not spread to distant parts of the body, and doctors believe it can be fully removed with surgery.
  • You are between 18 and 75 years old.
  • You are in good general health and able to carry out daily activities with little to no limitation (confirm with trial site).
  • You have not received any treatment before surgery, and you and your family prefer to have surgery as the first treatment.
  • Your blood counts, liver, and kidney functions are all within acceptable ranges as measured by blood tests (confirm with trial site for specific values).
  • You are willing and able to attend regular follow-up appointments over a long period of time.
  • You are willing to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

  • Your tissue sample shows more than 10% of a different cancer cell type, such as squamous cell carcinoma or neuroendocrine carcinoma.
  • You have a blockage in your digestive system that cannot be controlled, or you have repeated episodes of bleeding in your digestive tract.
  • You are unable to swallow tablets or oral medicines.
  • You currently have an active infection that requires treatment with medicines given throughout your body (such as intravenous antibiotics).
  • You have moderate to severe scarring of the liver (cirrhosis) from any cause.
  • You have a significant heart condition affecting how well your heart functions (confirm with trial site).
  • You have a history of heart attack, unstable chest pain (angina), stroke, or an uncontrolled irregular heartbeat.
  • It is expected that you would not be able to tolerate chemotherapy treatment after surgery.
  • You have another medical condition that means chemotherapy would not be safe for you.
  • You are pregnant or breastfeeding, have a history of psychiatric illness, or are unlikely to be able to follow the trial requirements reliably.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 010-87787120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year peritoneal metastasis-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov